Clinical trial Recruiting at 1 site Interventional Ages 20 to 40 Women only

Inositol and Metformin with Mediterranean or Low-Carb Diets in Women with PCOS

Official title: Comparison of Inositol and Metformin Administration in Mediterranean Diet and Low-Carbohydrate Diets in Women With Polycystic Ovary Syndrome

Run by Dicle University · NCT07770711 · Data updated 2026-11-12

This trial tests whether adding inositol, metformin, or folic acid to either a Mediterranean or a low-carbohydrate diet helps women with PCOS and insulin resistance lose weight and improve metabolic markers.

More Insulin Resistance trials

Quick facts

Study typeInterventional
Ages20 Years to 40 Years
SexWomen only
Enrollment90 (estimated)
SponsorDicle University
Academic / other
Locations1 site (Diyarbakır, Diyarbakır)
StatusRecruiting
StartedAugust 13, 2026
Main results expectedSeptember 2027
Study endsSeptember 2027
Registry record updatedOctober 16, 2026
Trial IDNCT07770711 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 20-40 with PCOS, obesity (BMI 30-40), and insulin resistance.

Probably not a fit

Those without insulin resistance, with BMI outside 30-40, or with conditions excluding participation may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, open-label study enrolls 102 obese women with PCOS and insulin resistance to compare six intervention groups combining two diet patterns (Mediterranean or low-carbohydrate) with three supplements (metformin, inositol, or folic acid) over two months. Primary outcome is the change in insulin resistance as measured by HOMA-IR, with secondary outcomes including body composition, biochemical parameters, and hedonic hunger. Participants are adults aged 20-40 with PCOS diagnosed by Rotterdam criteria and BMI 30-40 kg/m2. The trial is conducted at Dicle University Hospital in Diyarbakır, Turkey, and aims to clarify which dietary-supplement strategy best improves metabolic health in this population.

Why it matters

Potential benefit: If successful, the study could identify dietary and supplement combinations that better reduce insulin resistance and improve metabolic health in women with PCOS and obesity.

How similar studies have gone: Previous research suggests dietary patterns and supplements can impact PCOS-related metabolism, but direct head-to-head comparisons of these combinations are limited, making this approach relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women aged 20-40
* Diagnosed with PCOS (Rotterdam, 2004)
* Insulin resistant (newly diagnosed or diagnosed within the last 3 months)
* Obese according to the World Health Organization (2006) in grades 1 and 2 (BMI: 30-40 kg/m²)

Exclusion Criteria:

* Pregnant or breastfeeding women
* Those undergoing/contemplating IVF treatment
* Early menopause diagnosis
* Diabetes diagnosis, use of oral antidiabetic agents
* Chronic diseases (liver, kidney diseases, cancer)
* Psychiatric illnesses
* Those taking routine medication for any reason
* Use of hormonal contraceptive methods within the last 3 months
* Active smokers and alcohol users or social drinkers
* Change in body weight of more than 10% in the last 6 months for any reason

Where it's running

  • Dicle University Hospital
    Diyarbakır, Diyarbakır, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.